Sign in

CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Definium Therapeutics, Inc.

Sign in to watch
Ticker
DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
212-220-6633
Business address
ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
Former names
Mind Medicine (MindMed) Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,023,010
in 6 filings, $3.0M under 10b5-1 plans

Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-25 Karlin Daniel Chief Medical Officer Sale 10b5-1 −10,853 $36.57 $397K 792,846
2026-09-14 Karlin Daniel Chief Medical Officer Grant or award +200,000 803,699
2026-08-12 Karlin Daniel Chief Medical Officer Grant or award +100,000 603,282
2026-06-25 Karlin Daniel Chief Medical Officer Sale 10b5-1 −10,035 $45.03 $452K 503,282
2026-06-22 Karlin Daniel Chief Medical Officer Grant or award +100,000 513,317
2026-03-25 Karlin Daniel Chief Medical Officer Sale 10b5-1 −8,018 $18.47 $148K 413,317
2026-02-03 Karlin Daniel Chief Medical Officer Grant or award +150,000 575,025
2025-12-26 Karlin Daniel Chief Medical Officer Sale 10b5-1 −5,600 $13.15 $74K 425,025
2025-09-25 Karlin Daniel Chief Medical Officer Sale 10b5-1 −7,704 $9.77 $75K 430,625
2025-06-25 Karlin Daniel Chief Medical Officer Sale 10b5-1 −7,848 $6.80 $53K 438,329
2025-03-25 Karlin Daniel Chief Medical Officer Sale 10b5-1 −6,836 $6.74 $46K 446,177
2025-03-12 Karlin Daniel Chief Medical Officer Grant or award +115,000 453,013

Page 1 of 1 · 12 trades